Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 810.45 INR
Change Today -0.85 / -0.10%
Volume 24.3K
EMER On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

merck ltd (EMER) Snapshot

Open
817.95
Previous Close
811.30
Day High
820.00
Day Low
807.00
52 Week High
04/8/15 - 1,009
52 Week Low
12/1/14 - 670.00
Market Cap
13.5B
Average Volume 10 Days
18.2K
EPS TTM
26.04
Shares Outstanding
16.6M
EX-Date
03/30/15
P/E TM
31.1x
Dividend
6.00
Dividend Yield
0.74%
Current Stock Chart for MERCK LTD (EMER)

Related News

No related news articles were found.

merck ltd (EMER) Related Businessweek News

No Related Businessweek News Found

merck ltd (EMER) Details

Merck Limited manufactures and markets pharmaceuticals, bulk drugs, fine chemicals, and pigments in India. The company operates through two segments, Pharmaceuticals and Chemicals. The Pharmaceuticals segment offers multi-vitamin products under the Evion and Polybion; Concor for cardio-vascular care; Carbophage to treat metabolic disorders; Livogen for haematinics; and immuno-stimulators under the brands Immubron and Pedimune. It also provides consumer health care products, including vitamin B, cough and cold, and health protection and children health products under the Neurobion, Nasivion, Seven Seas, Electrobion, Maxepa, and Evion Cream brands. In addition, this segment exports its products to Asian and African countries, including Sri Lanka, Nepal, Lebanon, Kenya, Libya, and others. The Chemicals segment offers active pharmaceutical ingredients, excipients, and bio-pharmaceuticals for pharma and biopharma industries; bulk drug products, such as vitamin E, guaizulene, and thaimine disulphide; effect pigments for the automotive, cosmetics, plastics printing, and security industries; actives for the cosmetics industry; and functional and pearl lustre effect pigments. The company was formerly known as E. Merck Limited. The company was founded in 1967 and is based in Mumbai, India. Merck Limited is a subsidiary of Merck KGaA.

1,515 Employees
Last Reported Date: 03/17/15
Founded in 1967

merck ltd (EMER) Top Compensated Officers

Chief Financial Officer, Executive Director o...
Total Annual Compensation: 10.1M
Compensation as of Fiscal Year 2014.

merck ltd (EMER) Key Developments

Merck Ltd Announces Change of Corporate Office Address

Merck Ltd. announced that the company's office has moved to a new location. The Company's address details are: Godrej One, 8th floor Pirojshanagar, Eastern Express Highway, Vikhroli(E), Mumbai - 400079.

Merck Ltd. Appoints Bradley Simpson as Non-Executive Director

Bradley Simpson has been appointed as the non-executive director of Merck Ltd. with effect from May 21, 2015.

Merck Limited Reports Unaudited Stand-Alone Earnings Results for the First Quarter Ended March 31, 2015

Merck Limited reported unaudited stand-alone earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 1,897.080 million against INR 1,963.494 million for the same period previous year. Profit from operations before other income, finance costs & exceptional items was INR 85.061 million against loss of INR 31.276 million for the same period of previous year. Profit from ordinary activities before tax was INR 134.472 million against INR 23.73 million for the same period of previous year. Net profit was INR 96.194 million or INR 5.80 per diluted share compared to INR 10.855 million or INR 0.65 per diluted share for the same period of previous year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMER:IN 810.45 INR -0.85

EMER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $115.66 USD +0.62
Koninklijke DSM NV €51.27 EUR -0.53
Lonza Group AG SFr.130.20 CHF +3.00
Sigma-Aldrich Corp $139.47 USD -0.01
Thermo Fisher Scientific Inc $130.39 USD -0.56
View Industry Companies
 

Industry Analysis

EMER

Industry Average

Valuation EMER Industry Range
Price/Earnings 26.9x
Price/Sales 1.5x
Price/Book 2.4x
Price/Cash Flow 20.9x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK LTD, please visit www.merck.co.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.